Blood eosinophil counts might predict response to inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) and a history of exacerbations. We used data from the WISDOM trial to assess whether patients with COPD with higher blood eosinophil counts would be more likely to have exacerbations if ICS treatment was withdrawn.
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial / Watz, Henrik; Tetzlaff, Kay; Wouters, Emiel F. M; Kirsten, Anne; Magnussen, Helgo; Rodriguez Roisin, Roberto; Vogelmeier, Claus; Fabbri, Leonardo; Chanez, Pascal; Dahl, Ronald; Disse, Bernd; Finnigan, Helen; Calverley, Peter M. A.. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - 4:5(2016), pp. 390-398. [10.1016/S2213-2600(16)00100-4]
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
FABBRI, Leonardo;
2016
Abstract
Blood eosinophil counts might predict response to inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) and a history of exacerbations. We used data from the WISDOM trial to assess whether patients with COPD with higher blood eosinophil counts would be more likely to have exacerbations if ICS treatment was withdrawn.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2213260016001004-main.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
291.78 kB
Formato
Adobe PDF
|
291.78 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
